Related Experiment Video

Updated: Mar 9, 2026

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

8.7K

Diabetes microvascular complications-A clinical update

H Khalil1

  • 1Monash University, Monash Rural Health, Moe, Victoria, 3825, Australia.

Diabetes & Metabolic Syndrome
|December 21, 2016
PubMed
Abstract

Insights

Managing diabetes microvascular complications requires controlling blood pressure and blood glucose levels. Early detection through screening and addressing risk factors are key to preventing disease progression.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Research
  • Nephrology and Ophthalmology

Background:

  • Diabetes mellitus can lead to long-term organ damage and failure.
  • Microvascular disease arises in tissues with insulin-independent glucose uptake, directly reflecting blood glucose levels.
  • Metabolic injuries in diabetes alter blood flow, endothelial permeability, and coagulation, causing organ dysfunction and microvascular complications.

Purpose of the Study:

  • To systematically review empirical evidence on the management of diabetic microvascular complications.
  • To summarize current understanding of pathogenesis, risk factors, and interventions.
  • To highlight emerging research and potential future therapeutic targets.

Main Methods:

  • A systematic literature search was performed from 2000 to 2016.
  • Databases searched included Medline, Pubmed, Cochrane Central, and Google Scholar.
  • Keywords covered diabetic microvascular complications, pathogenesis, screening, risk factors, and management strategies.

Main Results:

  • Strong evidence links blood pressure and glycemic control to the progression of nephropathy and retinopathy.
  • These factors are recognized as independent risk factors for microvascular disease progression.
  • New research avenues exploring novel drug targets for future therapies were identified.

Conclusions:

  • Preventing microvascular disease necessitates managing aggravating risk factors.
  • Implementing screening programs is crucial for early detection and intervention.
  • Controlling blood pressure and glycemic control are paramount.
Keywords:
ManagementNephropathyNeuropathyPathogenesisRetinopathy

More Related Videos

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

14.2K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

2.1K

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
566